|
NCT04055220
|
A Randomized, Placebo-controlled, Double-blinded, Multicentre Study Evaluating the Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas (REGOSTA)
|
En recrutement
|
09 août 2023
|
|
NCT03624244
|
Randomized Comparative Prospective Multicentre Phase II Trial Evaluating Clinical Impact of Interruption VS Maintenance of AI in Patients with Locally Advanced/ Metastatic LGESS (BFR-ESS)
|
En recrutement
|
20 mars 2023
|
|
NCT04258137
|
Circulating DNA to Improve Outcome of Oncology PatiEnt: A Randomized Study - COPE Study (COPE)
|
Statut inconnu
|
20 mars 2023
|
|
NCT04008238
|
Prospective Identification of Predictive Biomarkers of Trabectedin Efficacy in Non-L Soft-tissue Sarcoma Patients (PIPER)
|
Statut inconnu
|
20 mars 2023
|
|
NCT03915678
|
Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors (AGADIR)
|
En recrutement
|
20 mars 2023
|
|
NCT03805022
|
Phase III Trial Investigating the Potential Benefit of Intensified Peri-operative Chemotherapy With in High-risk CINSARC Patients With Resectable Soft-tissue SARComas (CIRSARC)
|
Statut inconnu
|
20 mars 2023
|
|
NCT03275311
|
Epidemiological Strategy and Medical Economic (ESME) Research Program / Academic Real World Database: Evolution of the Therapeutic Care in Metastatic Breast Cancer Across the French Comprehensive Cancer Centers From 2008 (ESME-MBC)
|
En recrutement
|
20 mars 2023
|
|
NCT02789384
|
Prognostic Value of the CINSARC (Complexity Index in Sarcoma) Signature and Correlation With Chemotherapy Efficacy in Soft-tissue Sarcomas. A Biomarker Study. (NEOSarcomics ) (NEOSarcomics)
|
En recrutement
|
20 mars 2023
|
|
NCT02630368
|
A Phase I/II Study of Metronomic Cyclophosphamide and Oncolytic Poxvirus JX-594 in Patients With Advanced Hormone-receptor Positive and Triple Negative Breast Cancer and Advanced Soft Tissue Sarcoma (METROmaJX) (METROmaJX)
|
Statut inconnu
|
20 mars 2023
|
|
NCT02534649
|
Bergonie Institut Profiling : Fighting Cancer by Matching Molecular Alterations and Drugs in Early Phase Trials (BIP)
|
En recrutement
|
20 mars 2023
|
|
NCT04428554
|
Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients Without Progression and With no More Than Three Residual Metastatic Lesions Following First Line Systemic Therapy: a Prospective Randomized Comparative Phase II Trial (BLAD-RAD01)
|
En recrutement
|
20 mars 2023
|
|
NCT03848052
|
Epidemiological Strategy and Medical Economic (ESME) Research Program / Academic Real World Data Platform: Evolution of the Therapeutic Care in Lung Cancer in France Since 2015
|
En recrutement
|
05 novembre 2022
|
|
NCT02819362
|
Benefit of a Diagnostic MRI in Case of Pathological Nipple Discharge With Normal Mammography / Ultrasound.
|
Statut inconnu
|
05 novembre 2022
|
|
NCT00964171
|
A Phase II Trial to Assess the Efficacy of Efavirenz as Second-line Monotherapy for the Treatment of Advanced Pancreatic Adenocarcinomas.
|
Statut inconnu
|
29 octobre 2022
|